Global Azithromycin Tablets Market Research Report 2024

Publication ID:

PB507242914

Publication Date:

July 18, 2024

Pages:

102

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Azithromycin Tablets is an antibiotic that fights bacteria. It is used to treat many different types of infections caused by bacteria, such as respiratory infections, skin infections, ear infections, eye infections, and sexually transmitted diseases.
The global Azithromycin Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Azithromycin Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Azithromycin Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Azithromycin Tablets include Teva, CSPC, Novartis, wockhardt, Aurobindo Pharma, Sun Pharmaceutical Industries, Lupin Pharmaceuticals, Lannett Company and Apotex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Azithromycin Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Azithromycin Tablets.
Report Scope
The Azithromycin Tablets market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Azithromycin Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Azithromycin Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
CSPC
Novartis
wockhardt
Aurobindo Pharma
Sun Pharmaceutical Industries
Lupin Pharmaceuticals
Lannett Company
Apotex
Pfizer
Sinopharm
Yiling Pharmaceutical
Jilin Jingxin Pharmaceutical
Yatal Pharma
Hapharm Group
Kelun
Furen Medicines
Segment by Type
250mg
500mg
Segment by Application
Hospitals
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Azithromycin Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Azithromycin Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Azithromycin Tablets Market Overview
1.1 Product Overview and Scope of Azithromycin Tablets
1.2 Azithromycin Tablets Segment by Type
1.2.1 Global Azithromycin Tablets Market Value Comparison by Type (2024-2030)
1.2.2 250mg
1.2.3 500mg
1.3 Azithromycin Tablets Segment by Application
1.3.1 Global Azithromycin Tablets Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Global Azithromycin Tablets Market Size Estimates and Forecasts
1.4.1 Global Azithromycin Tablets Revenue 2019-2030
1.4.2 Global Azithromycin Tablets Sales 2019-2030
1.4.3 Global Azithromycin Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Azithromycin Tablets Market Competition by Manufacturers
2.1 Global Azithromycin Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Azithromycin Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Azithromycin Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Azithromycin Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Azithromycin Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Azithromycin Tablets, Product Type & Application
2.7 Azithromycin Tablets Market Competitive Situation and Trends
2.7.1 Azithromycin Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Azithromycin Tablets Players Market Share by Revenue
2.7.3 Global Azithromycin Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Azithromycin Tablets Retrospective Market Scenario by Region
3.1 Global Azithromycin Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Azithromycin Tablets Global Azithromycin Tablets Sales by Region: 2019-2030
3.2.1 Global Azithromycin Tablets Sales by Region: 2019-2024
3.2.2 Global Azithromycin Tablets Sales by Region: 2025-2030
3.3 Global Azithromycin Tablets Global Azithromycin Tablets Revenue by Region: 2019-2030
3.3.1 Global Azithromycin Tablets Revenue by Region: 2019-2024
3.3.2 Global Azithromycin Tablets Revenue by Region: 2025-2030
3.4 North America Azithromycin Tablets Market Facts & Figures by Country
3.4.1 North America Azithromycin Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Azithromycin Tablets Sales by Country (2019-2030)
3.4.3 North America Azithromycin Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Azithromycin Tablets Market Facts & Figures by Country
3.5.1 Europe Azithromycin Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Azithromycin Tablets Sales by Country (2019-2030)
3.5.3 Europe Azithromycin Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Azithromycin Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Azithromycin Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Azithromycin Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Azithromycin Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Azithromycin Tablets Market Facts & Figures by Country
3.7.1 Latin America Azithromycin Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Azithromycin Tablets Sales by Country (2019-2030)
3.7.3 Latin America Azithromycin Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Azithromycin Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Azithromycin Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Azithromycin Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Azithromycin Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Azithromycin Tablets Sales by Type (2019-2030)
4.1.1 Global Azithromycin Tablets Sales by Type (2019-2024)
4.1.2 Global Azithromycin Tablets Sales by Type (2025-2030)
4.1.3 Global Azithromycin Tablets Sales Market Share by Type (2019-2030)
4.2 Global Azithromycin Tablets Revenue by Type (2019-2030)
4.2.1 Global Azithromycin Tablets Revenue by Type (2019-2024)
4.2.2 Global Azithromycin Tablets Revenue by Type (2025-2030)
4.2.3 Global Azithromycin Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Azithromycin Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Azithromycin Tablets Sales by Application (2019-2030)
5.1.1 Global Azithromycin Tablets Sales by Application (2019-2024)
5.1.2 Global Azithromycin Tablets Sales by Application (2025-2030)
5.1.3 Global Azithromycin Tablets Sales Market Share by Application (2019-2030)
5.2 Global Azithromycin Tablets Revenue by Application (2019-2030)
5.2.1 Global Azithromycin Tablets Revenue by Application (2019-2024)
5.2.2 Global Azithromycin Tablets Revenue by Application (2025-2030)
5.2.3 Global Azithromycin Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Azithromycin Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Azithromycin Tablets Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 CSPC
6.2.1 CSPC Corporation Information
6.2.2 CSPC Description and Business Overview
6.2.3 CSPC Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSPC Azithromycin Tablets Product Portfolio
6.2.5 CSPC Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Azithromycin Tablets Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 wockhardt
6.4.1 wockhardt Corporation Information
6.4.2 wockhardt Description and Business Overview
6.4.3 wockhardt Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 wockhardt Azithromycin Tablets Product Portfolio
6.4.5 wockhardt Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aurobindo Pharma Azithromycin Tablets Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 Sun Pharmaceutical Industries
6.6.1 Sun Pharmaceutical Industries Corporation Information
6.6.2 Sun Pharmaceutical Industries Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceutical Industries Azithromycin Tablets Product Portfolio
6.6.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.7 Lupin Pharmaceuticals
6.6.1 Lupin Pharmaceuticals Corporation Information
6.6.2 Lupin Pharmaceuticals Description and Business Overview
6.6.3 Lupin Pharmaceuticals Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lupin Pharmaceuticals Azithromycin Tablets Product Portfolio
6.7.5 Lupin Pharmaceuticals Recent Developments/Updates
6.8 Lannett Company
6.8.1 Lannett Company Corporation Information
6.8.2 Lannett Company Description and Business Overview
6.8.3 Lannett Company Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lannett Company Azithromycin Tablets Product Portfolio
6.8.5 Lannett Company Recent Developments/Updates
6.9 Apotex
6.9.1 Apotex Corporation Information
6.9.2 Apotex Description and Business Overview
6.9.3 Apotex Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Apotex Azithromycin Tablets Product Portfolio
6.9.5 Apotex Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pfizer Azithromycin Tablets Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 Sinopharm
6.11.1 Sinopharm Corporation Information
6.11.2 Sinopharm Azithromycin Tablets Description and Business Overview
6.11.3 Sinopharm Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sinopharm Azithromycin Tablets Product Portfolio
6.11.5 Sinopharm Recent Developments/Updates
6.12 Yiling Pharmaceutical
6.12.1 Yiling Pharmaceutical Corporation Information
6.12.2 Yiling Pharmaceutical Azithromycin Tablets Description and Business Overview
6.12.3 Yiling Pharmaceutical Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yiling Pharmaceutical Azithromycin Tablets Product Portfolio
6.12.5 Yiling Pharmaceutical Recent Developments/Updates
6.13 Jilin Jingxin Pharmaceutical
6.13.1 Jilin Jingxin Pharmaceutical Corporation Information
6.13.2 Jilin Jingxin Pharmaceutical Azithromycin Tablets Description and Business Overview
6.13.3 Jilin Jingxin Pharmaceutical Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jilin Jingxin Pharmaceutical Azithromycin Tablets Product Portfolio
6.13.5 Jilin Jingxin Pharmaceutical Recent Developments/Updates
6.14 Yatal Pharma
6.14.1 Yatal Pharma Corporation Information
6.14.2 Yatal Pharma Azithromycin Tablets Description and Business Overview
6.14.3 Yatal Pharma Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Yatal Pharma Azithromycin Tablets Product Portfolio
6.14.5 Yatal Pharma Recent Developments/Updates
6.15 Hapharm Group
6.15.1 Hapharm Group Corporation Information
6.15.2 Hapharm Group Azithromycin Tablets Description and Business Overview
6.15.3 Hapharm Group Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Hapharm Group Azithromycin Tablets Product Portfolio
6.15.5 Hapharm Group Recent Developments/Updates
6.16 Kelun
6.16.1 Kelun Corporation Information
6.16.2 Kelun Azithromycin Tablets Description and Business Overview
6.16.3 Kelun Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Kelun Azithromycin Tablets Product Portfolio
6.16.5 Kelun Recent Developments/Updates
6.17 Furen Medicines
6.17.1 Furen Medicines Corporation Information
6.17.2 Furen Medicines Azithromycin Tablets Description and Business Overview
6.17.3 Furen Medicines Azithromycin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Furen Medicines Azithromycin Tablets Product Portfolio
6.17.5 Furen Medicines Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Azithromycin Tablets Industry Chain Analysis
7.2 Azithromycin Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Azithromycin Tablets Production Mode & Process
7.4 Azithromycin Tablets Sales and Marketing
7.4.1 Azithromycin Tablets Sales Channels
7.4.2 Azithromycin Tablets Distributors
7.5 Azithromycin Tablets Customers
8 Azithromycin Tablets Market Dynamics
8.1 Azithromycin Tablets Industry Trends
8.2 Azithromycin Tablets Market Drivers
8.3 Azithromycin Tablets Market Challenges
8.4 Azithromycin Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Teva
CSPC
Novartis
wockhardt
Aurobindo Pharma
Sun Pharmaceutical Industries
Lupin Pharmaceuticals
Lannett Company
Apotex
Pfizer
Sinopharm
Yiling Pharmaceutical
Jilin Jingxin Pharmaceutical
Yatal Pharma
Hapharm Group
Kelun
Furen Medicines

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂